Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized trial of chloroquine, hydroxychloroquine, or supportive care for hospitalized moderate to severe COVID-19
NL-OMON49317Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by University Medical Center Utrecht. Started Apr 2020; status: completed.
02
Drugs
chloroquinehydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON49317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49317.